Upstream Bioprocessing Market Size, Share Global Analysis Report, 2020–2026

Industry Insights

According to the report published by Facts & Factors, the global Upstream Bioprocessing market size was worth around USD 5.07 million in 2019 and is predicted to grow around USD 11.87 billion by 2026 with a compound annual growth rate (CAGR) of roughly 13.1% between 2020 and 2026. The report analyzes the global Upstream Bioprocessing market drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the Upstream Bioprocessing market.

The upstream bioprocessing market report analyzes and notifies the industry statistics at the global as well as regional and country levels in order to acquire a thorough perspective of the entire upstream bioprocessing market. The historical and past insights are provided for FY 2016 to FY 2019 whereas projected trends are delivered for FY 2020 to FY 2026. The quantitative and numerical data is represented in terms of both volume (Units) and value (USD Million) from FY 2016 – 2026.

This specialized and expertise-oriented industry research report scrutinizes the technical and commercial business outlook of the upstream bioprocessing industry. The report analyzes and declares the historical and current trends analysis of the upstream bioprocessing industry and subsequently recommends the projected trends anticipated to be observed in the upstream bioprocessing market during the upcoming years.

Key Insights from Primary Research

• As per our primary respondents, the global upstream bioprocessing market is set to grow annually at a rate of around 13.1%
• It was established through primary research that the global upstream bioprocessing  market was valued at around 5 USD billion in 2019
• The “In-house” category, on the basis of mode segmentation, is expected to dominate in terms of revenue, over the forecast period
• Based on the region, North America is expected to account for the revenue share in 2019 in the target market

Key Recommendations from Analysts

• As per our analysts, global upstream bioprocessing is growing at a high CAGR and various end-use industries are aware of this potential market and applications of upstream bioprocessing
• Growing at a CAGR of around 13.1%, the global upstream bioprocessing market provides numerous opportunities for all of the involved stakeholders across the entire value chain
• Our analysts have identified-house are dominating segment for the global upstream bioprocessing market in terms of mode segmentation

Market Share – By Mode

The quantitative data is further underlined and reinforced by comprehensive qualitative data which comprises various across-the-board market dynamics. The rationales which directly or indirectly impact the upstream bioprocessing industry are exemplified through parameters such as growth drivers, restraints, challenges, and opportunities among other impacting factors.

Throughout our research report, we have encompassed all the proven models and tools of industry analysis and extensively illustrated all the key business strategies and business models adopted in the upstream bioprocessing industry. The report provides an all-inclusive and detailed competitive landscape prevalent in the upstream bioprocessing market.

The report utilizes established industry analysis tools and models such as Porter’s Five Forces framework to analyze and recognize critical business strategies adopted by various stakeholders the upstream bioprocessing involved in the entire value chain of the upstream bioprocessing industry. The market report additionally employs SWOT analysis and PESTLE analysis models for further in-depth analysis.

The report study further includes an in-depth analysis of industry players' market shares and provides an overview of leading players' market position in the upstream bioprocessing sector. Key strategic developments in the upstream bioprocessing market competitive landscape such as acquisitions & mergers, inaugurations of different products and services, partnerships & joint ventures, MoU agreements, VC & funding activities, R&D activities, and geographic expansion among other noteworthy activities by key players of the upstream bioprocessing market are appropriately highlighted in the report.

The upstream bioprocessing market research report delivers an acute valuation and taxonomy of the upstream bioprocessing industry by practically splitting the market on the basis of different products, workflow, modes, and regions. Through the analysis of the historical and projected trends, all the segments and sub-segments were evaluated through the bottom-up approach, and different market sizes have been projected for FY 2020 to FY 2026.

The regional segmentation of the upstream bioprocessing industry includes the complete classification of all the major continents including North America, Latin America, Europe, Asia Pacific, and the Middle East & Africa. Further, country-wise data for the upstream bioprocessing industry is provided for the leading economies of the world.

Increasing research and development in the field of biosimilars and biomolecules is a major factor to drive the growth of the global market. The prevalence of chronic diseases is increasing across the globe which is expected to propel the growth of the global market in the near future.

However, high costs associated with the processing are expected to hamper target market growth in the near future. The global upstream bioprocessing market has been segmented on the basis of product, workflow, and mode.

Report Scope

Based on the product the target market is classified as Bioreactors Accessories, Cell Culture Products, Bioreactors/Fermenters, Bags & Containers, Filters, and Others. Based on the workflow segment the global market can be bifurcated into Cell Culture, Media Preparation, and Cell Separation. The mode segment is classified as outsourced and In-house. The In-house mode segment is expected to account for the largest market share in terms of revenue over the forecast period. Which outsourced segment is expected to grow at a significant rate during the forecasted year in the upstream bioprocessing industry?

The taxonomy of the Upstream Bioprocessing Market by its scope and segmentation is as follows:

Competitive Players

• Thermo Fisher Scientific
•  Samsung BioLogics
•  PBS Biotech Inc.
•  GE Healthcare
•  Merck KGaA
•  Sartorius AG
•  Eppendorf AG
• Applikon Biotechnology
• JM BIOCONNECT
• Corning Inc.,
• BoehringerIngelheim
• CellGenix GmbH
• Lonza
• Patheon
• CMC Biologics
• Danaher Corporation

Global Upstream Bioprocessing Market: By Product Segmentation Analysis (Customizable)

• Bioreactors/Fermenters
• Cell Culture Products
• Filters
• Bioreactors Accessories
• Bags & Containers
• Others

Global Upstream Bioprocessing Market: By Workflow Segmentation Analysis (Customizable)

• Media Preparation
• Cell Culture
• Cell Separation

Global Upstream Bioprocessing Market: By Mode Segmentation Analysis (Customizable)

• In-house
• Outsourced

Regional Segmentation Analysis (Customizable)

• North America
  • The U.S.
  • Canada
• Europe
  • Germany
  • The UK
  • France
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of the Middle East & Africa